FDA Warns Against Using Smartwatches For Blood Glucose Monitoring

Signage is seen outside of FDA headquarters in White Oak, Maryland

The Food and Drug Administration (FDA) has issued a warning to consumers regarding the use of smartwatches to measure blood glucose levels. The FDA cautions that these devices may not provide accurate or reliable results, potentially leading to serious health risks.

Smartwatches equipped with sensors claim to offer convenient and non-invasive ways to monitor blood glucose levels. However, the FDA emphasizes that these devices have not undergone rigorous testing to ensure their accuracy in measuring such a critical health parameter.